Stock 605077 ZHEJIANG HUAKANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Zhejiang Huakang Pharmaceutical Co., Ltd. Stock

Equities

605077

CNE100005477

Food Processing

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
23.01 CNY -1.88% Intraday chart for Zhejiang Huakang Pharmaceutical Co., Ltd. -1.50% +6.33%
Apr. 18 Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 10 Certain A Shares of Zhejiang Huakang Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024. CI

Financials

Sales 2024 * 3.59B 496M Sales 2025 * 4.27B 589M Capitalization 5.26B 726M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.46 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.23 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 1,350
Yield 2024 *
-
Yield 2025 *
-
Free-Float 43.98%
More Fundamentals * Assessed data

Chart Zhejiang Huakang Pharmaceutical Co., Ltd.

Dynamic Chart

Latest news about Zhejiang Huakang Pharmaceutical Co., Ltd.

Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Certain A Shares of Zhejiang Huakang Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 10-FEB-2024. CI
Zhoushan Huakang Biotechnology Co., Ltd. announced that it expects to receive CNY 700 million in funding from Zhejiang Huakang Pharmaceutical Co., Ltd. CI
Huakang Pharmaceutical Earmarks 248 Million Yuan for Corn Oil, Maltodextrin Plants MT
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhejiang Huakang Pharmaceutical Co., Ltd.(XSSC:605077) added to S&P Global BMI Index CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
HY Energy Plans to Sell Remaining Stake in Huakang Pharma CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhejiang Huakang Pharma Selling 1.3 Billion Yuan Convertible Bonds to Fund New Factory MT
Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077completed the acquisition of 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. CI
Zhejiang Huakang Pharma to Buy 95% of Thermal Power Firm for 522.5 Million Yuan MT
Zhejiang Huakang Pharmaceutical Co., Ltd. agreed to sign the Equity Transfer Agreement to acquire 95% each on Zhejiang Huahe Thermal Power Co., Ltd. and Zhoushan Xinyisheng Trading Co., Ltd. from Ningbo Ruishunjiu Trading Co., Ltd. for CNY 522.5 million. CI
Zhejiang Huakang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
HY Energy Plans to Unload Stake in Zhejiang Huakang Pharma CI
More news

Quotes and Performance

1 day-1.88%
1 week-1.50%
Current month+8.69%
1 month+6.04%
3 months+20.28%
6 months+1.72%
Current year+6.33%
More quotes

Highs and lows

1 week
22.79
Extreme 22.79
24.36
1 month
20.42
Extreme 20.42
26.15
Current year
15.57
Extreme 15.57
26.15
1 year
15.57
Extreme 15.57
28.07
3 years
15.57
Extreme 15.57
36.65
5 years
15.57
Extreme 15.57
64.08
10 years
15.57
Extreme 15.57
64.08
More quotes

Managers and Directors - Zhejiang Huakang Pharmaceutical Co., Ltd.

Managers TitleAgeSince
De Shui Chen CEO
 Chief Executive Officer 55 01-06-30
Jia Fa Wang DFI
 Director of Finance/CFO 56 23-04-12
Fang Ming Zheng CHM
 Chairman 56 04-03-31
Members of the board TitleAgeSince
Jun Feng Guo BRD
 Director/Board Member 55 18-10-29
De Shui Chen CEO
 Chief Executive Officer 55 01-06-30
Jian Ming Yu DFI
 Director of Finance/CFO 61 01-06-30
More insiders

Quotes

Date Price Change Volume
24-05-23 23.01 -1.88% 1,480,568
24-05-22 23.45 -1.80% 1,561,292
24-05-21 23.88 -0.79% 1,259,884
24-05-20 24.07 +4.06% 2,946,526
24-05-17 23.13 +0.78% 1,780,519

End-of-day quote Shanghai S.E., May 22, 2024

More quotes

Company Profile

Zhejiang Huakang Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of a variety of functional sugar alcohols and starch sugar products. The Company's main products are xylitol, sorbitol, maltitol and grape syrup. Its products are mainly used in food, beverage, daily chemical and other fields. The Company conducts its businesses within the China market and to overseas markets such as Europe, America and Asia.
Sector
Food Processing
Calendar
2024-08-14 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
23.01 CNY
Average target price
25 CNY
Spread / Average Target
+8.65%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Food Ingredients

1st Jan change Capi.
ZHEJIANG HUAKANG PHARMACEUTICAL CO., LTD. Stock Zhejiang Huakang Pharmaceutical Co., Ltd.
+6.33% 740M
FOSHAN HAITIAN FLAVOURING AND FOOD COMPANY LTD. Stock Foshan Haitian Flavouring and Food Company Ltd.
-2.27% 29.08B
INTERNATIONAL FLAVORS & FRAGRANCES INC. Stock International Flavors & Fragrances Inc.
+16.67% 24.5B
KIKKOMAN CORPORATION Stock Kikkoman Corporation
+5.98% 11.04B
LANCASTER COLONY CORPORATION Stock Lancaster Colony Corporation
+11.66% 5.19B
MEIHUA HOLDINGS GROUP CO.,LTD Stock MeiHua Holdings Group Co.,Ltd
+16.86% 4.44B
ANGEL YEAST CO., LTD Stock Angel Yeast Co., Ltd
-10.83% 3.79B
TATE & LYLE PLC Stock Tate & Lyle plc
+8.04% 3.43B
JONJEE HI-TECH INDUSTRIAL AND COMMERCIAL HOLDING CO.,LTD Stock Jonjee Hi-Tech Industrial and Commercial Holding Co.,Ltd
-3.88% 2.94B
KEWPIE CORPORATION Stock Kewpie Corporation
+23.69% 2.75B
Food Ingredients
  1. Stock Market
  2. Equities
  3. 605077 Stock